Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Deeks

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|January 12, 2001
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patientsN T Parkin, S G Deeks, M T Wrin, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adultsS G Deeks, P Barditch-Crovo, P S Lietman, et al.
AIDS Research and Human Retroviruses|May 15, 2001
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissuesM L Penn, M Myers, D A Eckstein, et al.
Nature Medicine|June 1, 2001
Impaired replication of protease inhibitor-resistant HIV-1 in human thymusC A Stoddart, T J Liegler, F Mammano, et al.
Journal of Virology|August 3, 2007
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolA C Karlsson, J M Chapman, B D Heiken, et al.
Nature Medicine|January 3, 2001
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasisL A Napolitano, R M Grant, S G Deeks, et al.
The New England Journal of Medicine|February 15, 2001
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremiaS G Deeks, T Wrin, T Liegler, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.
The Journal of Infectious Diseases|December 12, 1997
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trialS G Deeks, A Collier, J Lalezari, et al.
Mucosal Immunology|October 14, 2011
Altered distribution of mucosal NK cells during HIV infectionM Sips, G Sciaranghella, T Diefenbach, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|January 12, 2001
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patientsN T Parkin, S G Deeks, M T Wrin, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adultsS G Deeks, P Barditch-Crovo, P S Lietman, et al.
AIDS Research and Human Retroviruses|May 15, 2001
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissuesM L Penn, M Myers, D A Eckstein, et al.
Nature Medicine|June 1, 2001
Impaired replication of protease inhibitor-resistant HIV-1 in human thymusC A Stoddart, T J Liegler, F Mammano, et al.
Journal of Virology|August 3, 2007
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolA C Karlsson, J M Chapman, B D Heiken, et al.
Nature Medicine|January 3, 2001
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasisL A Napolitano, R M Grant, S G Deeks, et al.
The New England Journal of Medicine|February 15, 2001
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremiaS G Deeks, T Wrin, T Liegler, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.
The Journal of Infectious Diseases|December 12, 1997
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trialS G Deeks, A Collier, J Lalezari, et al.
Mucosal Immunology|October 14, 2011
Altered distribution of mucosal NK cells during HIV infectionM Sips, G Sciaranghella, T Diefenbach, et al.
Pageof 5